Treatment

Biological Markers of Ependymoma in Childhood and Adolescence (BIOMECA) 2

Radiotherapy-induced neurocognitive deficits in medulloblastoma: Human-equivalent modelling and randomised pre-clinical trials to identify effective pharmacological interventions for clinical application

Investigating Treatment Resistance in Paediatric-Type Diffuse High-Grade Glioma

Investigating the clinical relevance of the remaining 15 subtypes and establish whether they can be used prospectively to guide treatment. 

Characterising and targeting the treatment resistant population in B-ALL following Inotuzumab Ozogamicin treatment

MYB-directed therapy for paediatric AML